869901-52-0 Purity
---
If you have any other questions or need other size, please get a quote.
Specification
A solution of (cyanomethylene)tributylphosphorane (262 L, 1.00 mmol), (tetrahydrofuran-3-yl)methanol (51 mg, 0.50 mmol), and 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (97 mg, 0.5 mmol) in degassed 1,4-dioxane (2 mL) was prepared in a sealed microwave tube at room temperature under nitrogen. The solution was subjected to microwave irradiation at 150 °C for 30 minutes and then allowed to cool to room temperature.
· Subsequently, 1-bromo-4-methoxybenzene (94 mg, 0.50 mmol), potassium carbonate (207 mg, 1.50 mmol), and [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with CH2Cl2 (40.8 mg, 0.05 mmol) were introduced to the solution under vacuum and nitrogen. After adding degassed water (1 mL) under nitrogen, the mixture was stirred at 120 °C for 20 minutes.
· The reaction mixture was then diluted with EtOAc (25 mL) and water (15 mL), followed by extraction of the aqueous layer with EtOAc (15 mL). The combined organic layers were washed with saturated brine (15 mL), dried with MgSO4, filtered, and concentrated to yield the crude product.
· The crude product was further purified by preparative HPLC (5µ silica, 30 mm diameter, 100 mm length), using a gradient of water (with 1% NH3OH) and MeCN as eluents to obtain 4-(4-methoxyphenyl)-1-((tetrahydrofuran-3-yl)methyl)-1H-pyrazole (89 mg, 69%) in the form of a beige solid.
The IUPAC Name of the compound is 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole.
The molecular formula is C9H15BN2O2.
The CAS number of the compound is 269410-08-4.
The molecular weight of the compound is 194.04 g/mol.
The compound has 1 hydrogen bond donor count.
The compound has 3 hydrogen bond acceptor counts.
The compound has 1 rotatable bond count.
The exact mass of the compound is 194.1226579 g/mol.
The topological polar surface area of the compound is 47.1Ų.
Yes, the compound is canonicalized.
Reference: [1] Patent: WO2008/116620, 2008, A1, . Location in patent: Page/Page column 171
Reference: [1] Patent: WO2018/93569, 2018, A1, . Location in patent: Page/Page column 189
Reference: [1] Journal of Medicinal Chemistry, 2009, vol. 52, # 24, p. 7934 - 7937
Reference: [1]Patent: WO2007/138472,2007,A2 .Location in patent: Page/Page column 32
Reference: [1]Patent: WO2016/123796,2016,A1 .Location in patent: Page/Page column 49; 50
Reference: [1]Patent: US2008/90856,2008,A1 .Location in patent: Page/Page column 41
* For details of the synthesis route, please refer to the original source to ensure accuracy.